Cargando…

Short term outcome of patients attending a renal-immunology clinic in central India

BACKGROUND: Glomerular diseases (GDs) and other renal immunologic diseases are an important cause of morbidity and mortality. Providing a single point of service in collaboration with various specialists at a renal immunology clinic for such patients is not novel, but outcomes have not been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Atlani, M, Kapoor, NK, Joshi, D, Sutar, R, Sharma, T, Joshi, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196291/
https://www.ncbi.nlm.nih.gov/pubmed/35259787
http://dx.doi.org/10.4103/jpgm.JPGM_1320_20
_version_ 1784727153981521920
author Atlani, M
Kapoor, NK
Joshi, D
Sutar, R
Sharma, T
Joshi, A
author_facet Atlani, M
Kapoor, NK
Joshi, D
Sutar, R
Sharma, T
Joshi, A
author_sort Atlani, M
collection PubMed
description BACKGROUND: Glomerular diseases (GDs) and other renal immunologic diseases are an important cause of morbidity and mortality. Providing a single point of service in collaboration with various specialists at a renal immunology clinic for such patients is not novel, but outcomes have not been reported. Here, we report the short-term outcome of Indian patients attending our clinic. METHODS: This single-center prospective cohort study enrolled biopsy-proven immunologically-mediated adults with renal diseases between April 2018 and December 2019, and followed them for six months. The primary end point for the analysis was an incidence of end-stage renal disease (ESRD) or loss of >50% estimated glomerular filtration rate (eGFR) and patient survival at six months. Secondary endpoints were the rate of complete or partial remission, and impact of demographic factors. RESULTS: Ninety two patients underwent renal biopsy for suspected immunological renal diseases. Fourteen (15.2%) cases were excluded for nonimmune etiologies, whereas 78 (84.7%) confirmed cases of immune etiology were included. Most common primary GD (n = 51) (93.5%) was membranous nephropathy (n = 20) (25.6%), whereas lupus nephritis was the most common (n = 8) (29.6%) secondary GD. Overall, 10 (12.8%) patients reached renal endpoint of ESRD or >50% fall in eGFR. Focal segmental glomerulosclerosis (FSGS) (27%) patients had worst renal outcome. Patient survival was 94.8%. Thirty patients (38.4%) achieved complete, whereas 24 each (30.7%) achieved partial remission and remained resistant to disease specific therapies, respectively. Univariate analysis identified hypertension, severity of hypertension, and resistance to achieve proteinuria remission as significantly associated (P < 0.001) factors with poor renal outcome. CONCLUSIONS: The present study shows that short term renal outcome of Indian patients with renal immune diseases remains poor. FSGS remains the GD with the worst renal outcome. Hypertension, its severity, failure to achieve proteinuria remission were significantly associated with poor renal outcomes.
format Online
Article
Text
id pubmed-9196291
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91962912022-06-15 Short term outcome of patients attending a renal-immunology clinic in central India Atlani, M Kapoor, NK Joshi, D Sutar, R Sharma, T Joshi, A J Postgrad Med Original Article BACKGROUND: Glomerular diseases (GDs) and other renal immunologic diseases are an important cause of morbidity and mortality. Providing a single point of service in collaboration with various specialists at a renal immunology clinic for such patients is not novel, but outcomes have not been reported. Here, we report the short-term outcome of Indian patients attending our clinic. METHODS: This single-center prospective cohort study enrolled biopsy-proven immunologically-mediated adults with renal diseases between April 2018 and December 2019, and followed them for six months. The primary end point for the analysis was an incidence of end-stage renal disease (ESRD) or loss of >50% estimated glomerular filtration rate (eGFR) and patient survival at six months. Secondary endpoints were the rate of complete or partial remission, and impact of demographic factors. RESULTS: Ninety two patients underwent renal biopsy for suspected immunological renal diseases. Fourteen (15.2%) cases were excluded for nonimmune etiologies, whereas 78 (84.7%) confirmed cases of immune etiology were included. Most common primary GD (n = 51) (93.5%) was membranous nephropathy (n = 20) (25.6%), whereas lupus nephritis was the most common (n = 8) (29.6%) secondary GD. Overall, 10 (12.8%) patients reached renal endpoint of ESRD or >50% fall in eGFR. Focal segmental glomerulosclerosis (FSGS) (27%) patients had worst renal outcome. Patient survival was 94.8%. Thirty patients (38.4%) achieved complete, whereas 24 each (30.7%) achieved partial remission and remained resistant to disease specific therapies, respectively. Univariate analysis identified hypertension, severity of hypertension, and resistance to achieve proteinuria remission as significantly associated (P < 0.001) factors with poor renal outcome. CONCLUSIONS: The present study shows that short term renal outcome of Indian patients with renal immune diseases remains poor. FSGS remains the GD with the worst renal outcome. Hypertension, its severity, failure to achieve proteinuria remission were significantly associated with poor renal outcomes. Wolters Kluwer - Medknow 2022 2022-03-04 /pmc/articles/PMC9196291/ /pubmed/35259787 http://dx.doi.org/10.4103/jpgm.JPGM_1320_20 Text en Copyright: © 2022 Journal of Postgraduate Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Atlani, M
Kapoor, NK
Joshi, D
Sutar, R
Sharma, T
Joshi, A
Short term outcome of patients attending a renal-immunology clinic in central India
title Short term outcome of patients attending a renal-immunology clinic in central India
title_full Short term outcome of patients attending a renal-immunology clinic in central India
title_fullStr Short term outcome of patients attending a renal-immunology clinic in central India
title_full_unstemmed Short term outcome of patients attending a renal-immunology clinic in central India
title_short Short term outcome of patients attending a renal-immunology clinic in central India
title_sort short term outcome of patients attending a renal-immunology clinic in central india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196291/
https://www.ncbi.nlm.nih.gov/pubmed/35259787
http://dx.doi.org/10.4103/jpgm.JPGM_1320_20
work_keys_str_mv AT atlanim shorttermoutcomeofpatientsattendingarenalimmunologyclinicincentralindia
AT kapoornk shorttermoutcomeofpatientsattendingarenalimmunologyclinicincentralindia
AT joshid shorttermoutcomeofpatientsattendingarenalimmunologyclinicincentralindia
AT sutarr shorttermoutcomeofpatientsattendingarenalimmunologyclinicincentralindia
AT sharmat shorttermoutcomeofpatientsattendingarenalimmunologyclinicincentralindia
AT joshia shorttermoutcomeofpatientsattendingarenalimmunologyclinicincentralindia